---
layout: post
title: "Alternative or Streamlined Mechanisms for Complying With the Current Good Manufacturing Practice Requirements for Combination Products; List Under the 21st Century Cures Act"
date: 2026-02-05 19:00:42 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-19713
original_published: 2022-09-13 00:00:00 +0000
significance: 8.00
---

# Alternative or Streamlined Mechanisms for Complying With the Current Good Manufacturing Practice Requirements for Combination Products; List Under the 21st Century Cures Act

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** September 13, 2022 00:00 UTC
**Document Number:** 2022-19713

## Summary

As required by the 21st Century Cures Act (Cures Act), the Food and Drug Administration (FDA, Agency, or we) is finalizing a list of alternative or streamlined mechanisms for complying with the current good manufacturing practice (CGMP) requirements for combination products. A combination product is a product composed of any combination of a drug, a device, and/or a biological product.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/09/13/2022-19713/alternative-or-streamlined-mechanisms-for-complying-with-the-current-good-manufacturing-practice)
- API: https://www.federalregister.gov/api/v1/documents/2022-19713

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
